127 related articles for article (PubMed ID: 31974031)
1. The clinical characteristics of patients with acute leukemia or stem cell transplantation exhibiting immune based platelet refractoriness.
Zhou Z; Gao Y; Li X; Ren J; Liu Y; Li J
Transfus Apher Sci; 2020 Jun; 59(3):102725. PubMed ID: 31974031
[TBL] [Abstract][Full Text] [Related]
2. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
[TBL] [Abstract][Full Text] [Related]
3. The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation.
Li G; Liu F; Mao X; Hu L
Transfus Apher Sci; 2011 Aug; 45(1):21-4. PubMed ID: 21798807
[TBL] [Abstract][Full Text] [Related]
4. Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.
Fu Q; Xu L; Zhang X; Wang Y; Chang Y; Liu K; Huang X
Sci China Life Sci; 2018 May; 61(5):569-577. PubMed ID: 28914433
[TBL] [Abstract][Full Text] [Related]
5. ABO non-identical platelet transfusions, immune platelet refractoriness and platelet support.
Han MH; Badami KG
Br J Haematol; 2024 May; 204(5):2097-2102. PubMed ID: 38419302
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.
Scott A; Baidya S; Butler J; Morris K; Thornton A; Kennedy GA
Transfusion; 2016 Jan; 56(1):164-9. PubMed ID: 26264674
[TBL] [Abstract][Full Text] [Related]
7. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.
Comont T; Tavitian S; Bardiaux L; Fort M; Debiol B; Morère D; Bérard E; Delabesse E; Luquet I; Martinez S; Huguet F; Récher C; Bertoli S
Leuk Res; 2017 Oct; 61():62-67. PubMed ID: 28910610
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.
Hu X; Cai H; Zheng L; Luo Y; Zhou J; Hui Y; Dai Z; Lin H; Li D; Xiao Y; Huang L; Zhou J
Cancer Med; 2020 Jul; 9(14):4941-4948. PubMed ID: 32419364
[TBL] [Abstract][Full Text] [Related]
9. [The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases].
Zuo YL; Zhai JP; Li Y; Jiang M; Cui QY; Tang XW; Zhao YM; Zhang JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1923-1928. PubMed ID: 34893135
[TBL] [Abstract][Full Text] [Related]
10. Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes.
Tanoue S; Konuma T; Kato S; Oiwa-Monna M; Isobe M; Jimbo K; Takahashi S; Tojo A
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1873-1880. PubMed ID: 29753839
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
Seike K; Fujii N; Asano N; Ohkuma S; Hirata Y; Fujii K; Sando Y; Nakamura M; Naito K; Saeki K; Meguri Y; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Tsubaki K; Otsuka F; Maeda Y
Transfusion; 2020 Mar; 60(3):473-478. PubMed ID: 31970799
[TBL] [Abstract][Full Text] [Related]
12. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
13. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
14. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
Beligaswatte A; Tsiopelas E; Humphreys I; Bennett G; Robinson K; Davis K; Bardy P
Br J Haematol; 2013 Aug; 162(3):409-12. PubMed ID: 23651440
[TBL] [Abstract][Full Text] [Related]
15. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
16. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
[TBL] [Abstract][Full Text] [Related]
17. Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness.
Chellaiya GK; Nair CK; Raghavan V; Pandian RJ; Vinod R; Murugesan M
Asian J Transfus Sci; 2021; 15(1):90-93. PubMed ID: 34349464
[TBL] [Abstract][Full Text] [Related]
18. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
19. Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.
Wang Y; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Lee SJ; Savage SA; Gadalla SM
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1054-1058. PubMed ID: 28389255
[TBL] [Abstract][Full Text] [Related]
20. Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia.
Liu Y; Liang B; Liu Y; Wei G; Wu W; Yang L; Yang L; Huang H; Xie J; Hu Y
Front Pharmacol; 2021; 12():702152. PubMed ID: 34366854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
